Do GLP-1 Medications Cause Gallbladder Problems?

Yes — both semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) carry a small but measurable increase in gallbladder-related events, including gallstones (cholelithiasis) and gallbladder inflammation (cholecystitis). The risk is highest during periods of rapid weight loss and at higher doses.

Why GLP-1s and gallstones are linked

Two mechanisms are usually cited. First, rapid weight loss of any kind — from bariatric surgery, very-low-calorie diets, or aggressive GLP-1 dosing — causes the liver to dump more cholesterol into bile, which can crystallize into stones. Second, GLP-1 receptor agonists appear to slow gallbladder emptying directly, meaning bile sits longer and is more likely to form sludge or stones.

The FDA label for semaglutide and tirzepatide both list cholelithiasis as a known adverse reaction. In clinical trials, gallbladder events occurred in roughly 1–2% of patients on higher doses, compared to under 1% on placebo. Not a huge absolute number, but not zero.

Symptoms to watch for

Most gallstones are silent. The ones that cause trouble usually announce themselves clearly:

Sudden, severe pain in the upper-right abdomen — often radiating to the right shoulder or back
Pain that worsens after a fatty meal
Nausea or vomiting beyond your usual GLP-1 baseline
Fever or chills (sign of infection — go to urgent care)
Yellowing of skin or eyes (jaundice — emergency)

GLP-1 nausea and gallbladder nausea can feel similar, which is part of why people often dismiss early symptoms. The tell is location and timing: gallbladder pain is typically focal, intense, and often happens 30–60 minutes after eating something rich.

What people commonly do to lower the risk

There's no proven prevention protocol, but a few things come up repeatedly in clinical discussions:

Slow, steady weight loss: losing more than ~1.5% of body weight per week is associated with higher gallstone risk. If your weight is dropping fast, talk to your doctor about pacing.
Don't skip fat entirely: ultra-low-fat eating can paradoxically increase gallstone risk because the gallbladder doesn't contract often enough. Moderate dietary fat keeps bile moving.
Stay hydrated: dehydration concentrates bile.
Some doctors prescribe ursodiol (a bile acid) for patients at high risk during rapid weight loss, though this is case-by-case.

If you've had gallstones before, mention it to your prescriber before starting or escalating a GLP-1.

Tracking matters here

Side effects on GLP-1s are noisy. Logging your dose, weight trajectory, GI symptoms, and any unusual abdominal pain makes it much easier to flag something new — and gives your doctor real data instead of vague recall.

Trace is a private logbook for exactly this. You can log GLP-1 doses, symptoms, weight, and notes all in one place, with everything stored locally on your device behind Face ID. If a pain pattern shows up after a dose increase, it's right there in your timeline.

Frequently Asked Questions

Should I stop my GLP-1 if I get gallstones?

That's a decision for your doctor. Some people continue at a lower dose, some pause, some have the gallbladder removed and resume treatment. Don't stop on your own — abrupt discontinuation has its own consequences for blood sugar and appetite.

Can I take a GLP-1 if I've already had my gallbladder removed?

Yes, this is generally fine and is actually common. Without a gallbladder you can't get gallstones, though some people experience looser stools that GLP-1-related slowing can sometimes help balance.

Does tirzepatide have less gallbladder risk than semaglutide?

Trial data is mixed and not directly comparable. Both carry similar warnings. The bigger driver appears to be the speed of weight loss rather than the specific drug.

How long after starting a GLP-1 do gallbladder issues usually show up?

Most reported cases occur within the first 6–12 months, often during or shortly after periods of rapid weight loss or dose escalation. But stones can form silently and only cause symptoms much later.